Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8201–8250 of 76387
Effective April 1, 2025, following ten years of board membership, Israel Niv retired as a member of the board of directors (the “Board”) of Actelis Networks, Inc. (the “Company”), and as member of the committees of the Board.
On March 26, 2025, Abhishek Bawa notified the board of directors (the "Board") of ClimateRock (the "Company") of his resignation as Chief Financial Officer of the Company, effective on March 26, 2025.
On April 1, 2025, iHeartMedia, Inc. (the “Company”) announced that it intends to nominate Robert Millard as a director of the Company at the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”).
On March 26, 2025, Brad Gerstner informed the Company of his intention not to stand for re-election to the Board at the Company’s 2025 Annual Meeting to focus on other commitments and accordingly, his term will end on the date of the 2025 Annual Meeting.
First Northwest Bancorp ("First Northwest") and its wholly owned subsidiary First Fed Bank ("First Fed" and, together with First Northwest, the "Company") has announced that on March 27, 2025, Phyllis Nomura was appointed Executive Vice President and Chief Financial Officer / Treasurer of the Company, effective immediately.
On March 27, 2025, BJ North, Plumas Bank’s Executive Vice President and Chief Banking Officer, notified the bank that she intends to retire effective on July 15, 2025.
On March 26, 2025, the board of directors of the Company (the “Board”) appointed Greg Lipschitz as the Chief Executive Officer of the Company.
On April 1, 2025 (the “ Effective Date ”), Universal Biosensors, Inc. (the “ Company ”) announced that John Sharman resigned from his position as Chief Executive Officer and Managing Director on the Board of Directors (the “ Board ”) of the Company, effective on the Effective Date.
On the Effective Date, the Company announced that the Board appointed Peter Mullin as Chief Executive Officer and Managing Director of the Board, effective as of the Effective Date.
The Company has appointed Rajal Mehta as Interim Chief Financial Officer effective upon Mr. Edwards’ departure.
On March 27, 2025, Thomas J. Edwards, Jr., Executive Vice President, Chief Financial Officer and Chief Operating Officer of Capri Holdings Limited (the “ Company ”) notified the Company of his decision to resign from his position, effective June 20, 2025, to pursue another opportunity.
Frank E. Jenkins, Jr., a former director of Village, was appointed to the board of directors of TowneBank effective as of the effective time of the Transaction.
James E. Hendricks, Jr., former President and Chief Executive Officer of Village, became a Senior Executive Vice President of TowneBank at the effective time of the Transaction.
agreed that Dr. Jansen would step down as Chief Medical Officer effective March 31, 2025
On March 31, 2025, the Board appointed Lawrence S. Massaro to serve as a member of the board of directors (the “ Board ”) of TXO Partners GP, LLC (the “ General Partner ”), the general partner of TXO Partners, L.P. (the “ Partnership ”), effective April 1, 2025.
Effective as of April 1, 2025, Salvatore Mulia, a member of the NewtekOne, Inc. Board of Directors (the “Board”) since 2004, retired as a member of the Board.
Coincident to Ms. Lachance's appointment, Scott Shuda was appointed Executive Chairman of the Company's Board.
The Board has appointed Carrie Lachance as the new CEO, effective as of the Separation Date.
Mr. DiIorio will step down as the Company's Chief Executive Officer ("CEO"), effective May 19, 2025
will continue to serve on the Board until the end of his term, which expires May 15, 2025
On March 28, 2025, Thomas Slater submitted his notice of retirement as Executive Vice President and Chief Credit Officer of Patriot Bank, N.A. (the "Bank"), a wholly owned subsidiary of Patriot National Bancorp, Inc., effective May 15, 2025.
Kevin W. Bush as an outside director
the retirement of Wm. Ronald Duffey on March 31, 2025
Ronnie M. Hendricks as a member at-large director
Christopher L. Stephens as a director for member group 3
On April 1, 2025, Antonio M. Gotto, Jr., M.D., D. Phil. notified the Board of the Company of his decision to resign from the Board, including his position as a member of the Nominating and Corporate Governance Committee of the Board (the “Nominating and Corporate Governance Committee”), effective June 1, 2025.
On April 1, 2025, Nicole Vitullo notified the Board of Directors (the “Board”) of Esperion Therapeutics, Inc. (the “Company”) of her decision to resign from the Board, including her positions as a member of the Audit Committee of the Board (the “Audit Committee”) and Compliance Committee of the Board, effective June 1, 2025.
On April 1, 2025, upon the recommendation of the Nominating and Corporate Governance Committee, the Board elected Robert E. Hoffman to the Board, effective April 1, 2025.
On March 27, 2024, Ms. Avital Rosenberg notified the board of directors (the “Board”) of the Company of her resignation from the Board, effective immediately.
promoted Stephen McAndrew, Ph.D., the Company’s current Chief Business Officer, to President and Chief Business Officer
As a result of the passing of Pankaj Mohan, President, Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of Sonnet BioTherapeutics Holdings, Inc. (the “Company”), on March 31, 2025, the Board unanimously appointed Raghu Rao, 62, a current member of the Board, as interim Chief Executive Officer and promoted Stephen McAndrew, Ph.D., the Company’s current Chief Business Officer, to President and Chief Business Officer.
the Board unanimously appointed Raghu Rao, 62, a current member of the Board, as interim Chief Executive Officer
On March 27, 2025, Kezar Life Sciences, Inc. (the “Company”) appointed Pichi (Pattie) Chiang as the Company's principal accounting officer, effective April 1, 2025.
appointed Ms. Robyn Liska as Interim Chief Financial Officer of the Company effective March 31, 2025.
Eric Williams stepped down as Executive Vice President, Chief Financial Officer of the Company effective March 30, 2025.
On March 30, 2025, the Board of Directors (“Board”) of SkyWater Technology, Inc. (the “Company”) elected Timothy E. Baxter, Andrew D. C. LaFrence and Tammy J. Miller to serve on the Board effective March 31, 2025.
On March 30, 2025, the Board of Directors (“Board”) of SkyWater Technology, Inc. (the “Company”) elected Timothy E. Baxter, Andrew D. C. LaFrence and Tammy J. Miller to serve on the Board effective March 31, 2025.
On March 30, 2025, the Board of Directors (“Board”) of SkyWater Technology, Inc. (the “Company”) elected Timothy E. Baxter, Andrew D. C. LaFrence and Tammy J. Miller to serve on the Board effective March 31, 2025.
On March 27, 2025, the board of directors of the Company (the “Board”) appointed Gabriel Loh as an independent director of the Company.
Mark Lappe will continue in his roles as Chief Executive Officer and Chairperson of the Board of Directors, but will no longer hold the title of President.
On April 1, 2025, Inhibrx Biosciences, Inc. (the “Company”) announced the appointment of David J. Matly, M.B.A. as President, effective April 1, 2025, adding to his current role as Chief Commercial and Business Development Officer.
On March 31, 2025, Brendan P. Eckelman, Ph.D. informed the Company of his intention to resign as EVP, Chief Scientific Officer of the Company, effective immediately, to establish a newly-formed private biotechnology company, where he will be founder and Chief Executive Officer.
Danny G. Allouche will cease serving as the Company’s Interim Chief Financial Officer and principal financial officer on March 31, 2025; he will continue serving as the Company’s Senior Vice President and Chief Strategy and Corporate Development Officer.
Effective April 1, 2025, Gregory S. Lovins, Senior Vice President and Chief Financial Officer of Avery Dennison Corporation (the “Company”), will resume serving as the Company’s principal financial officer following a previously disclosed medical leave of absence that began on November 14, 2024.
On March 28, 2025, Jennifer Gravelle, Vice President, Chief Financial Officer and Treasurer of Kingstone Companies, Inc. (the “Company”), advised the Company that she will be resigning from her positions for personal reasons to pursue other opportunities.
at which time Tammy Romo will step down from that role
the Board of Directors (the “Board”) of Southwest Airlines Co. (the “Company”) unanimously appointed J. Ryan Martinez to assume the responsibilities of the Company’s principal accounting officer, effective April 1, 2025
On March 31, 2025, the Board of Directors (the “Board”) of Jack in the Box Inc. (the “Company”) appointed Mr. Lance Tucker to serve as the Company’s Chief Executive Officer and as a member of the Board, effective immediately.
On March 5, 2025, Sleep Number Corporation (the “Company”) announced that the Board of Directors unanimously appointed Linda Findley to the position of President and Chief Executive Officer and Board member, effective as of April 7, 2025.
On March 31, 2025, Mohawk Industries, Inc. (the “Company”) announced the appointment of David L. Repp as Senior Vice President - Chief Accounting Officer and Corporate Controller, effective March 31, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.